337 related articles for article (PubMed ID: 33905540)
1. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng SM; Moore HS
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD003424. PubMed ID: 33905540
[TBL] [Abstract][Full Text] [Related]
2. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng SM; Moore HS
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD003424. PubMed ID: 27546383
[TBL] [Abstract][Full Text] [Related]
3. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng SM; Franchini AJ
Cochrane Database Syst Rev; 2014 Jul; (7):CD003424. PubMed ID: 25019293
[TBL] [Abstract][Full Text] [Related]
4. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng SM; Francini AJ
Cochrane Database Syst Rev; 2012 Apr; (4):CD003424. PubMed ID: 22513912
[TBL] [Abstract][Full Text] [Related]
5. Drug therapies for reducing gastric acidity in people with cystic fibrosis.
Ng SM; Jones AP
Cochrane Database Syst Rev; 2003; (2):CD003424. PubMed ID: 12804466
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acid supplementation for cystic fibrosis.
Watson H; Stackhouse C
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD002201. PubMed ID: 32275788
[TBL] [Abstract][Full Text] [Related]
7. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
Green J; Gilchrist FJ; Carroll W
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012619. PubMed ID: 29894558
[TBL] [Abstract][Full Text] [Related]
8. Drug treatments for managing cystic fibrosis-related diabetes.
Onady GM; Stolfi A
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD004730. PubMed ID: 33075159
[TBL] [Abstract][Full Text] [Related]
9. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Carter B; Putman M
Cochrane Database Syst Rev; 2018 Dec; 12(12):CD008901. PubMed ID: 30557452
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates for osteoporosis in people with cystic fibrosis.
Jeffery TC; Chang AB; Conwell LS
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD002010. PubMed ID: 36625789
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
Somaraju UR; Solis-Moya A
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD008227. PubMed ID: 27878805
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
Somaraju UR; Solis-Moya A
Cochrane Database Syst Rev; 2014 Oct; (10):CD008227. PubMed ID: 25310479
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic enzyme replacement therapy for people with cystic fibrosis.
Somaraju URR; Solis-Moya A
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD008227. PubMed ID: 32761612
[TBL] [Abstract][Full Text] [Related]
14. Oral calorie supplements for cystic fibrosis.
Smyth RL; Rayner O
Cochrane Database Syst Rev; 2017 May; 5(5):CD000406. PubMed ID: 28470972
[TBL] [Abstract][Full Text] [Related]
15. Recombinant growth hormone therapy for cystic fibrosis in children and young adults.
Thaker V; Carter B; Putman M
Cochrane Database Syst Rev; 2021 Aug; 8(8):CD008901. PubMed ID: 34424546
[TBL] [Abstract][Full Text] [Related]
16. Inhaled corticosteroids for cystic fibrosis.
Balfour-Lynn IM; Welch K
Cochrane Database Syst Rev; 2016 Aug; (8):CD001915. PubMed ID: 27552284
[TBL] [Abstract][Full Text] [Related]
17. Ataluren and similar compounds (specific therapies for premature termination codon class I mutations) for cystic fibrosis.
Aslam AA; Higgins C; Sinha IP; Southern KW
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD012040. PubMed ID: 28102546
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological treatment of children with gastro-oesophageal reflux.
Tighe M; Afzal NA; Bevan A; Hayen A; Munro A; Beattie RM
Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD008550. PubMed ID: 25419906
[TBL] [Abstract][Full Text] [Related]
19. Probiotics for people with cystic fibrosis.
Coffey MJ; Garg M; Homaira N; Jaffe A; Ooi CY
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012949. PubMed ID: 31962375
[TBL] [Abstract][Full Text] [Related]
20. Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis.
Carroll W; Green J; Gilchrist FJ
Cochrane Database Syst Rev; 2021 Dec; 12(12):CD012619. PubMed ID: 34936085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
